Ramsay Partners with IMS MAXIMS for Next Decade

IMS MAXIMSRamsay Health Care UK, one of the leading providers of independent hospital services in England, has signed a 10-year contract with IMS MAXIMS to provide an open source electronic patient record (EPR) system and clinical modules to improve patient satisfaction and outcomes.

The agreement aims to help the independent healthcare sector provider achieve its commitment to continuous service improvement. "It's about putting the patient at the heart of everything we do," says Andrew Till, corporate service director at Ramsay Health Care UK. "We are always striving to provide a safe, high quality seamless service and IT is a cornerstone to achieving this mission."

The contract will see the implementation of the full openMAXIMS product suite released to healthcare providers last summer. Till said he was confident with IMS MAXIMS' open source development processes to enhancing the code in the future.

The suite includes a patient administration system, and solutions for order communications and results, eDischarge, integrated care pathways, theatre scheduling, bed management and clinical noting.

Other functionality to be introduced as part of the contract includes electronic prescribing, medical device integration, voice recognition, direct booking capability, and a pharmacy system.

The move away from paper records will see clinicians access patient information at anytime, in any location, via desktop and mobile devices, supporting productivity improvements. Till said the need to have patient information "readily available" for clinicians at the bedside would increase response times when accessing patient information at the point-of-care.

Furthermore, the integration capabilities of IMS MAXIMS means there is less manual intervention when integrating data across the IT solution set, resulting in a quicker and more coordinated service for both clinicians and patients.

The openMAXIMS technology will be deployed across all 32 Ramsay Health Care UK sites, with an average of 1,500 active concurrent users of the system at any one time.

Till said IMS MAXIMS’ reputation and the range of functionality it could offer was key to selecting the company as the preferred supplier: "IMS MAXIMS is well established in the UK health market. We saw a number of principles in the company that reflected our own ethos at Ramsay such as integrity and professionalism, which wholly supported the commitment to enter a 10-year deal."

Shane Tickell, CEO of IMS MAXIMS, concluded: "As no two healthcare providers, or indeed, no two clinicians are the same, we know how important it is to ensure we meet the clinical, management and financial needs of any organisation when scoping healthcare technology. This contract reflects the hard work and time invested to understand Ramsay’s requirements for a strategic IT solution.

"As we look forward to this long-term partnership, I believe the extensive knowledge and experience of both organisations will enable the delivery of safer, more efficient care for the benefit of patients."

About Ramsay Health Care UK
Ramsay Health Care UK is one of the leading private hospital operators in the UK with 36 facilities across England. These provide a comprehensive range of elective care specialties to insured, self-pay and NHS patients.

About openMAXIMS
Electronic patient record (EPR) provider IMS MAXIMS released the open source code for its full MAXIMS suite, including its electronic patient record and patient administration system (PAS) free of charge to the NHS in June 2014. Earlier this year, IMS MAXIMS was named the only open source EPR and PAS supplier in a ‘catalogue’ designed to support NHS England’s technology fund two, officially called the Integrated Digital Care Fund.

About IMS MAXIMS
IMS MAXIMS is an electronic patient record provider working towards better, safer patient care. Specialists in developing clinical and administrative software solutions for healthcare providers, IMS MAXIMS currently supports more than 150 organisations, 11 million patient records in the UK, and 1.9 million patient records in Ireland, approx 50% of the population, as well as 20,000 users of IMS MAXIMS products.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...